David C Hodgson is Director of Royalty Pharma plc. Currently has a direct ownership of 25,714 shares of RPRX, which is worth approximately $679,621. The most recent transaction as insider was on Jun 07, 2024, when has been sold 9,293 shares (Class A Ordinary Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 25.7K
0% 3M change
56.59% 12M change
Total Value Held $679,621

DAVID C HODGSON Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 07 2024
BUY
Grant, award, or other acquisition
-
9,293 Added 26.55%
25,714 Class A Ordinary Shares
Jun 23 2023
BUY
Grant, award, or other acquisition
-
7,747 Added 32.05%
16,421 Class A Ordinary Shares
Jul 08 2022
BUY
Grant, award, or other acquisition
-
2,346 Added 21.29%
8,674 Class A Ordinary Shares
Jun 24 2022
BUY
Grant, award, or other acquisition
-
6,328 Added 50.0%
6,328 Class A Ordinary Shares

Also insider at

TNET
TRINET GROUP, INC. Industrials
ALHC
Alignment Healthcare, Inc. Healthcare
DCH

David C Hodgson

Director
New York, NY

Track Institutional and Insider Activities on RPRX

Follow Royalty Pharma plc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RPRX shares.

Notify only if

Insider Trading

Get notified when an Royalty Pharma PLC insider buys or sells RPRX shares.

Notify only if

News

Receive news related to Royalty Pharma plc

Track Activities on RPRX